Literature DB >> 9009298

Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads.

T Sawai1, K Tomono, K Yanagihara, Y Yamamoto, M Kaku, Y Hirakata, H Koga, T Tashiro, S Kohno.   

Abstract

We describe a novel mouse model of acute staphylococcal pneumonia induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads. For comparison, we also used various strains of bacteria, including three strains of S. aureus, two strains of Staphylococcus epidermidis, one strain of Streptococcus pyogenes, three strains of Pseudomonas aeruginosa, and one strain of Klebsiella pneumoniae. All except two strains of S. aureus were cleared rapidly from the lungs. When S. aureus NUMR1 enmeshed in agar beads was injected intravenously, the organisms concentrated and remained in the lung for a period longer than several weeks. Multiple lung abscesses were evident macroscopically, and histological examination of the infected lung showed multiple lung abscesses around the pulmonary arterioles, consisting of bacterial colonies encircled with fibrin filaments and surrounded by inflammatory cells of neutrophils and macrophages. When 14 strains of clinically isolated S. aureus were injected intravenously, the number of bacteria recovered from the lung tissue 7 days after infection correlated with the titer of staphylocoagulase (P < 0.01) but not with the titer of clumping factor. Injection of coagulase-deficient mutant strain DU5843 was associated with a markedly reduced number of viable bacteria isolated from the lung, compared with its coagulase-positive parental strain DU5789. Our results suggest that coagulase may play a role in the development of blood-borne staphylococcal pneumonia in our model. Our animal model is simple and reproducible and resembles blood-borne staphylococcal pneumonia in humans, and it could be useful for investigating the pathogenicity or treatment of staphylococcal pulmonary infection, including infections with methicillin-resistant S. aureus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9009298      PMCID: PMC174618          DOI: 10.1128/iai.65.2.466-471.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  A study of virulence factors with induced mutants of Staphylococcus aureus.

Authors:  J C van der Vijver; M M van Es-Boon; M F Michel
Journal:  J Med Microbiol       Date:  1975-05       Impact factor: 2.472

2.  The effect of complement depletion on lung clearance of bacteria.

Authors:  G N Gross; S R Rehm; A K Pierce
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

Review 3.  Infections due to Staphylococcus aureus.

Authors:  D M Musher; S O McKenzie
Journal:  Medicine (Baltimore)       Date:  1977-09       Impact factor: 1.889

Review 4.  The major medical complications of heroin addiction.

Authors:  D B Louria; T Hensle; J Rose
Journal:  Ann Intern Med       Date:  1967-07       Impact factor: 25.391

5.  The role of coagulase in the defence of Staphylococcus aureus against phagocytosis.

Authors:  M Cawdery; W D Foster; B C Hawgood; C Taylor
Journal:  Br J Exp Pathol       Date:  1969-08

6.  A rat model of chronic respiratory infection with Pseudomonas aeruginosa.

Authors:  H A Cash; D E Woods; B McCullough; W G Johanson; J A Bass
Journal:  Am Rev Respir Dis       Date:  1979-03

7.  Activation of a pro-enzyme by a stoichiometric reaction with another protein. The reaction between prothrombin and staphylocoagulase.

Authors:  H C Hemker; B M Bas; A D Muller
Journal:  Biochim Biophys Acta       Date:  1975-01-30

8.  Virulence and immunity of Staphylococcus aureus BB and certain deficient mutants.

Authors:  N Hasegawa; C L San Clemente
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

9.  Pulmonary alveolar macrophage. Defender against bacterial infection of the lung.

Authors:  E Goldstein; W Lippert; D Warshauer
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

10.  Pulmonary infection of mice with Staphylococcus aureus.

Authors:  T F DeMaria; F A Kapral
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

View more
  31 in total

Review 1.  Encapsulating peritoneal sclerosis: a single-center experience and review of the literature.

Authors:  Konstantina Trigka; Periklis Dousdampanis; Maggie Chu; Saimah Khan; Mufazzal Ahmad; Joanne M Bargman; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2010-10-06       Impact factor: 2.370

2.  Influenza virus primes mice for pneumonia from Staphylococcus aureus.

Authors:  Amy R Iverson; Kelli L Boyd; Julie L McAuley; Lisa R Plano; Mark E Hart; Jonathan A McCullers
Journal:  J Infect Dis       Date:  2011-01-28       Impact factor: 5.226

Review 3.  Exploring Staphylococcus aureus pathways to disease for vaccine development.

Authors:  Andrea DeDent; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Semin Immunopathol       Date:  2011-12-01       Impact factor: 9.623

4.  The staphylocoagulase family of zymogen activator and adhesion proteins.

Authors:  P Panizzi; R Friedrich; P Fuentes-Prior; W Bode; P E Bock
Journal:  Cell Mol Life Sci       Date:  2004-11       Impact factor: 9.261

5.  The extracellular adherence protein (Eap) of Staphylococcus aureus inhibits wound healing by interfering with host defense and repair mechanisms.

Authors:  Athanasios N Athanasopoulos; Matina Economopoulou; Valeria V Orlova; Astrid Sobke; Darius Schneider; Holger Weber; Hellmut G Augustin; Sabine A Eming; Uwe Schubert; Thomas Linn; Peter P Nawroth; Muzaffar Hussain; Hans-Peter Hammes; Mathias Herrmann; Klaus T Preissner; Triantafyllos Chavakis
Journal:  Blood       Date:  2005-11-29       Impact factor: 22.113

Review 6.  Fibrinogen Is at the Interface of Host Defense and Pathogen Virulence in Staphylococcus aureus Infection.

Authors:  Ya-Ping Ko; Matthew J Flick
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

7.  Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii.

Authors:  P Stutzmann Meier; J M Entenza; P Vaudaux; P Francioli; M P Glauser; P Moreillon
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

8.  Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection.

Authors:  Katsunori Yanagihara; Yukihiro Kaneko; Toyomitsu Sawai; Yoshitsugu Miyazaki; Kazuhiro Tsukamoto; Yoichi Hirakata; Kazunori Tomono; Jun-Ichi Kadota; Takayoshi Tashiro; Ikuo Murata; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

Review 9.  Staphylococcus aureus Aggregation and Coagulation Mechanisms, and Their Function in Host-Pathogen Interactions.

Authors:  H A Crosby; J Kwiecinski; A R Horswill
Journal:  Adv Appl Microbiol       Date:  2016-08-04       Impact factor: 5.086

10.  The role of staphylothrombin-mediated fibrin deposition in catheter-related Staphylococcus aureus infections.

Authors:  Thomas Vanassche; Marijke Peetermans; Lucas N L Van Aelst; Willy E Peetermans; Jan Verhaegen; Dominique M Missiakas; Olaf Schneewind; Marc F Hoylaerts; Peter Verhamme
Journal:  J Infect Dis       Date:  2013-03-26       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.